Configuration of a High-Content Imaging Platform for Hit Identification and Pharmacological Assessment of JMJD3 Demethylase Enzyme Inhibitors
Authors:
Open Access
- 1 January 2012
- journal article
- research article
- Published by Elsevier in SLAS Discovery
- Vol. 17 (1) , 108-120
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- An assessment of histone-modification antibody qualityNature Structural & Molecular Biology, 2010
- Jmjd3 and UTX Play a Demethylase-Independent Role in Chromatin Remodeling to Regulate T-Box Family Member-Dependent Gene ExpressionMolecular Cell, 2010
- Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genesNature, 2010
- Regulation of NF-κB by NSD1/FBXL11-dependent reversible lysine methylation of p65Proceedings of the National Academy of Sciences, 2009
- Jmjd3 contributes to the control of gene expression in LPS‐activated macrophagesThe EMBO Journal, 2009
- Epigenetic reprogramming during wound healing: loss of polycomb‐mediated silencing may enable upregulation of repair genesEMBO Reports, 2009
- Somatic mutations of the histone H3K27 demethylase gene UTX in human cancerNature Genetics, 2009
- Identification of JmjC domain-containing UTX and JMJD3 as histone H3 lysine 27 demethylasesProceedings of the National Academy of Sciences, 2007
- The Histone H3 Lysine-27 Demethylase Jmjd3 Links Inflammation to Inhibition of Polycomb-Mediated Gene SilencingCell, 2007
- Baculovirus as versatile vectors for protein expression in insect and mammalian cellsNature Biotechnology, 2005